FDA's Marks Sees 'Two Or Three Year Window' To Transform Gene Therapy Environment

Gene therapy
FDA is focusing on ways to accelerate development of gene therapies • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership